Supporting our systems: Addressing immunosenescence and improving adult immunisation in Europe
6 Nov, 2025
Since 1960, Europe’s population has grown by 27%. Over the same period, the number of people aged 65 and over has increased by 181%. There can be no denying that Europe is an ageing continent and now faces many social, economic and health challenges.
Immunosenescence is the gradual weakening of the immune system that occurs naturally as we age; the process typically accelerates from the age of 50 onwards. This poses a particular healthcare challenge for European governments and institutions. Given that one in five Europeans today is aged 65 or over, a growing proportion of the population is now prone to the effects of immunosenescence.
This decline in immune function not only makes older people more susceptible to disease and infection: it also poses a risk to the efficacy of the immunisation programmes designed to prevent those conditions. This means that adult immunisation programmes across Europe are increasingly vulnerable to immunosenescence.
We must act on immunosenescence now if we are to protect preventive health interventions, like immunisation, from being undermined. National governments and European institutions must strengthen existing adult immunisation programmes, while investing in preventative healthcare and health promotion. We believe they should:
- Lower age recommendations for vaccination and create flexible age-based recommendations that reflect healthy life expectancy.
- Make greater investment in vaccine research and technology by increasing funding via national healthcare budgets.
- Address health inequalities and vaccination access barriers by working with local communities and charities to deliver vaccinations in appropriate locations.
- Improve vaccination communication and education by healthcare providers by providing more funding to ensure key messages are delivered better to patients.
- Promote preventative interventions and better lifestyle choices by increasing preventative health spend and creating a European Parliament “Sub-Committee on Healthy Ageing” that spearheads an EU healthy ageing strategy.
Read the full report and the Call to Action document below.
This report has been sponsored by CSL Seqirus. ILC has retained editorial control of all written outputs.

